Stomach pacemaker could quiet chronic nausea

NCT ID NCT06464926

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a device called the Enterra Therapy System, which is like a pacemaker for the stomach, can reduce chronic nausea and vomiting in people whose stomach empties normally. The device is surgically implanted and sends mild electrical pulses to the stomach. The trial will enroll 148 adults who have had nausea for at least 6 months and haven't gotten relief from drugs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Enterra Therapy System (implantable gastric electrical stimulator)
What this could lead to
If it works, this could offer a new treatment option for people with chronic nausea and vomiting that hasn't responded to drugs.
What could go wrong
This is an early-stage trial with only 148 participants. The device requires surgery and carries risks like infection or lead problems. It may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NAUSEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bronchiolitis Obliterans Syndrome Nausea Vomiting

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Baylor College of Medicine

    RECRUITING

    Houston, Texas, 77030, United States

  • CHU de Bordeaux

    RECRUITING

    Pessac, France

  • CHU de Rouen

    RECRUITING

    Rouen, 76031, France

  • Cleveland Clinic Foundation

    RECRUITING

    Cleveland, Ohio, 44195, United States

  • Endeavor Health

    RECRUITING

    Evanston, Illinois, 60201, United States

  • Functional Gut Clinic

    RECRUITING

    Manchester, M3 4BG, United Kingdom

  • Hackensack Meridian

    RECRUITING

    Neptune City, New Jersey, 07753, United States

  • Hoag Hospital

    RECRUITING

    Newport Beach, California, 92663, United States

  • Hôpital Edouard Herriot - CHU de Lyon

    RECRUITING

    Lyon, 69003, France

  • Hôpital Louis-Mourier

    RECRUITING

    Colombes, France

  • Indiana University Health

    RECRUITING

    Indianapolis, Indiana, 46202, United States

  • Keck Medicine of USC

    RECRUITING

    Los Angeles, California, 90033, United States

  • King's College Hospital NHS Foundation Trust

    RECRUITING

    London, SE5 9RS, United Kingdom

  • Manchester University NHS Foundation Trust

    RECRUITING

    Manchester, M23 9LT, United Kingdom

  • Mayo Clinic Arizona

    RECRUITING

    Scottsdale, Arizona, 85259, United States

  • Sahlgrenska Universitetssjukhuset

    RECRUITING

    Gothenburg, 413 45, Sweden

  • Sutter Health

    RECRUITING

    San Francisco, California, 94109, United States

  • Temple Digestive Disease Center

    RECRUITING

    Philadelphia, Pennsylvania, 19140, United States

  • UZ Leuven

    RECRUITING

    Leuven, Belgium

  • University College London Hospital

    RECRUITING

    London, NW1 6DB, United Kingdom

  • University of Louisville

    RECRUITING

    Louisville, Kentucky, 40202, United States

  • University of South Florida

    RECRUITING

    Tampa, Florida, 33606, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.